openPR Logo
Press release

Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2028

03-12-2021 04:47 PM CET | Health & Medicine

Press release from: Fact.MR

Atrial Fibrillation (AF) Ablation Market by Procedure

Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces the efficiency and performance of the heart. The symptoms for atrial fibrillation include weakness, heart palpitations, and shortness of breath. The irregular impulses revoke the heart’s natural pacemaker and cannot control the rhythm of the heart. In normal conditions, the heart beats 60–100 times per minute while in case of atrial fibrillation the heart beat changes to about 100–175 beats per minute which is cured by atrial fibrillation ablation.

To remain ‘ahead’ of your competitors, request for a sample @
https://www.factmr.com/connectus/sample?flag=S&rep_id=2269

Atrial Fibrillation (AF) Ablation Market: Segmentation

Tentatively, the global atrial fibrillation ablation market can be segmented on the basis of product type, technology and end users.

Based on product type, the global atrial fibrillation ablation market is segmented as:
Cryoablation Probes and Pens
Radiofrequency Clamps
Temperature controlled radiofrequency Ablators
Radiofrequency ablation catheters

Based on technology, the global atrial fibrillation ablation market is segmented as:
Radiofrequency energy
Cryoablation

Based on end users, the global atrial fibrillation ablation market is segmented as:
Hospitals
Super specialty clinics

Atrial Fibrillation Ablation Market: Overview

Atrial fibrillation ablation is a technique in which the irregular and out-of-synchronized electric signals are treated. For atrial fibrillation ablation two types of technologies are used, i.e., radiofrequency energy and cryoablation. The cryoballon delivers a refrigerant. The tip of the catheters are advanced into the vein which when reach the target freeze the tissue which is in contact with the balloon. While in case of radio frequency energy, heat is passed around the pulmonary veins to create a circular scar which in return will reduce the frequency of atrial fibrillation. The global market of atrial fibrillation is expected to witness high growth over the forecast period. With the advancement of technology, majority of the devices are introduced in the market which generate competition among the local as well as regional players. The market for atrial fibrillation ablation is expected to increase with the rise in the cardiac diseases. The geriatric population is expected to be affected the most.

Request Full Report With TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2269

Atrial Fibrillation (AF) ablation Market: Key Players

The global market for atrial fibrillation ablation is highly fragmented. Examples of some of the key players operating in the global atrial fibrillation ablation market are Boston Scientific Corporation, Medtronic, AtriCure, Inc. LuxCath LLC, BIOTRONIK UK Ltd, Biosense Webster, Inc, MicroPort Scientific Corporation, Baylis Medical Company, Inc and Lepu (Beijing) Medical Devices Co., Ltd. and AFreeze, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Customized Report As Per Your Requirements@
https://www.factmr.com/connectus/sample?flag=RC&rep_id=2269

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Research Insight: https://www.factmr.com/report/2269/atrial-fibrillation-ablation-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2028 here

News-ID: 2255832 • Views: 273

More Releases from Fact.MR

11-17-2022 | Health & Medicine
Fact.MR
ENT Devices Market Revenue Will Grow 1.8x By 2032
The examination report distributed by Fact.MR on the ENT Devices Market is expected to offer dependable information on different key variables forming the development bend of the market. This report fills in as a rich wellspring of data for key elements, for example, strategy producers, end-use ventures, financial backers, and assessment pioneers. The section represented an extensive offer in the ENT Devices Market in conjecture period 2022 to 2032. The offer
11-17-2022 | Health & Medicine
Fact.MR
Lateral Flow Assays Market Is Projected To Grow At A CAGR Of 4.7% Over The Comin …
The examination report distributed by Fact.MR on the Lateral Flow Assays Market is expected to offer dependable information on different key variables forming the development bend of the market. This report fills in as a rich wellspring of data for key elements, for example, strategy producers, end-use ventures, financial backers, and assessment pioneers. The section represented an extensive offer in the Lateral Flow Assays Market in conjecture period 2022 to
Automated Storage and Retrieval Systems Market estimates to reach a market value …
The global market for automated storage and retrieval systems (ASRS) is expected to grow from 10.2 billion in 2022 to 24 billion by 2032. During the forecast period of 2022-32, ASRS demand is expected to grow at a rate of more than 9.1% per year, primarily due to its use in retail warehouses. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=1869 These computerized inventory management systems are preferred by various manufacturing
Triethanolamine Market is expected to close at 5% CAGR during Forecast 2021-2031
Fact.MR forecasts a close to 5% CAGR in triethanolamine sales from 2021 to 2031. In terms of volume, demand is expected to rise at a CAGR of around 4% over the same time period. By 2031, the market is expected to be worth approximately US$ 1.7 billion. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=1810 Demand for 99% purity triethanolamine is expected to increase by 144 BPS over the next ten

All 5 Releases


More Releases for Atrial

Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market
Atrial Fibrillation Market is predicted to grow at a double digit CAGR over the forecast period (2017 to 2023). Atrial fibrillation, also denoted as AF, is an irregular or fast heart rhythm. It raises the dangers of chest pain, heart strokes, congestive heart failure, or cardiac discomfort. The typical indications of AF are dizziness, confusion, fainting, or tiredness. Therapeutic advancements and the burgeoning aged populace also drive the industry. Supportive clinical
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Market Opportunity Analysis, 2018-2026
Atrial fibrillation, also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. Most episodes of atrial fibrillation have no symptoms or fewer symptoms such as intermittent heart palpitations, lightheadedness, fainting, chest pain, and shortness of breath. Atrial fibrillation is linked with an elevated risk of heart failure, stroke, and dementia. The disease is a kind of supraventricular tachycardia. Risk factors associated
Atrial Septal Defect Market Future Opportunities2017 - 2025
Global Atrial Septal Defect Market: Outlook Atrial septal defect is one of the most common congenital cardiac diseases and usually affects women more than men. It is characterized by a hole or defect in the interatrial septum that separates the heart’s two upper chambers, i.e., atria. The opening in the septum usually closes when the baby is born, but in few cases if the opening does not close, the hole
Atrial Fibrillation Market Analysis, Forecast, and Assessment 2026
Increasing prevalence of common diseases and conditions such as obesity, diabetes, hypertension, etc., are leading to the risk of various heart problems. Moreover, the rise in people suffering from high blood pressure, and valvular heart disease due to the rheumatic fever are some of the most common risk factors for atrial fibrillation. Along with the increasing number of people suffering from atrial fibrillation, especially among the geriatric population. There has